» Articles » PMID: 38178712

The Role of Cognitive Reserve and Clinical Symptoms in the Association Between Genetic Liability for Educational Attainment and Functioning in First-episode Psychosis: A Mediation Analysis

Abstract

Background: Polygenic risk scores for educational attainment (PRS), cognitive reserve (CR), and clinical symptoms are associated with functioning in first-episode psychosis (FEP). Nevertheless, the mechanisms underlying their complex interaction are yet to be explored. This study assessed the mediating role of CR and clinical symptoms, both negative (NS) and positive (PS), on the interrelationship between PRS and functionality, one year after a FEP.

Methods: A total of 162 FEP patients underwent clinical, functional, and genetic assessments. Using genome-wide association study summary results, PRS were constructed for each individual. Two mediation models were performed. The parallel mediation model explored the relationship of PRS with functionality through CR and clinical symptoms. The serial mediation model tested a causal chain of the three mediators: CR, NS, and PS. Mediation analysis was performed using the PROCESS function V.4.1 in SPSS V.22.

Results: A serial mediation model revealed a causal chain for PRS > CR > NS > Functionality ( = -0.35, 95%CI [-0.85, -0.04],  < 0.05). The model fit the data satisfactorily (CFI = 1.00; RMSEA = 0.00; SRMR = 7.2 × 10). Conversely, no parallel mediation was found between the three mediators, PRS and functionality and the model poorly fit the data (CFI = 0.30; RMSEA = 0.25; SRMR = 0.11).

Conclusions: Both CR and NS mediate the relationship between PRS and functionality at one-year follow-up, using serial mediation analysis. This may be relevant for prevention and personalized early intervention to reduce illness impact and improve functional outcomes in FEP patients.

Citing Articles

European Psychiatry: 2024 in review.

Frangou S, Fiorillo A Eur Psychiatry. 2025; :1-7.

PMID: 39865842 PMC: 11883779. DOI: 10.1192/j.eurpsy.2025.4.


Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia.

Pezzella P, Caporusso E, Mucci A, Bucci P, Giordano G, Amore M Schizophr Bull Open. 2024; 5(1):sgae020.

PMID: 39221412 PMC: 11362673. DOI: 10.1093/schizbullopen/sgae020.

References
1.
Walhovd K, Howell G, Ritchie S, Staff R, Cotman C . What are the earlier life contributions to reserve and resilience?. Neurobiol Aging. 2019; 83:135-139. DOI: 10.1016/j.neurobiolaging.2019.04.014. View

2.
Amoretti S, Verdolini N, Mezquida G, Rabelo-da-Ponte F, Cuesta M, Pina-Camacho L . Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique. Eur Neuropsychopharmacol. 2021; 47:112-129. DOI: 10.1016/j.euroneuro.2021.01.095. View

3.
Santoro M, Ota V, de Jong S, Noto C, Spindola L, Talarico F . Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort. Transl Psychiatry. 2018; 8(1):174. PMC: 6119191. DOI: 10.1038/s41398-018-0230-7. View

4.
Green M, Kern R, Braff D, Mintz J . Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull. 2001; 26(1):119-36. DOI: 10.1093/oxfordjournals.schbul.a033430. View

5.
Lambert S, Abraham G, Inouye M . Towards clinical utility of polygenic risk scores. Hum Mol Genet. 2019; 28(R2):R133-R142. DOI: 10.1093/hmg/ddz187. View